
Neuro-explicit AI
for Drug Discovery
Applying cutting-edge ML methods to accelerate compound screening, perform in-silico predictions of pharmacokinetic properties and toxicity of drug candidates, improve drug efficacy and effectiveness, and design new drug candidates.
About
The Neuro-explicit AI for Drug Discovery (NEDD) project was launched in 2022 at Saarland University with the goal of combining the expertise of the Saarland Informatics Campus (SIC) with the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS). The novel interdisciplinary collaboration across campus integrates pharmaceutical research with the latest advances in the area of machine learning.
Our mission is to apply cutting-edge machine learning methods to accelerate compound screening, perform in-silico predictions of pharmacokinetic properties and toxicity of drug candidates, improve drug efficacy and effectiveness, and design new drug candidates.
Publications (from our group)
2026
Assay-Based Machine Learning: Rethinking Evaluation in Drug Discovery
2026 — Digital Discovery
2026 — Artificial Intelligence in the Life Sciences (AILSCI)
2025
2025 — Living Journal of Computational Molecular Science (LiveCoMS)
2024
Guided docking as a data generation approach facilitates structure-based machine learning on kinases
2024 — Journal of Chemical Information and Modeling (JCIM)
Structural activity prediction models recover known binding modes (Poster abstract)
2024 — ICML'24 Workshop ML for Life and Material Science: From Theory to Industry Applications. International Conference on Machine Learning (ICML-2024)